GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » ROE %

Sipai Health Technology Co (HKSE:00314) ROE % : -19.07% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sipai Health Technology Co's annualized net income for the quarter that ended in Dec. 2023 was HK$-358 Mil. Sipai Health Technology Co's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was HK$1,875 Mil. Therefore, Sipai Health Technology Co's annualized ROE % for the quarter that ended in Dec. 2023 was -19.07%.

The historical rank and industry rank for Sipai Health Technology Co's ROE % or its related term are showing as below:

HKSE:00314' s ROE % Range Over the Past 10 Years
Min: -14.64   Med: -14.64   Max: -14.47
Current: -14.47

During the past 3 years, Sipai Health Technology Co's highest ROE % was -14.47%. The lowest was -14.64%. And the median was -14.64%.

HKSE:00314's ROE % is ranked worse than
91.58% of 95 companies
in the Medical Distribution industry
Industry Median: 7.14 vs HKSE:00314: -14.47

Sipai Health Technology Co ROE % Historical Data

The historical data trend for Sipai Health Technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co ROE % Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
ROE %
- - -14.64

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
ROE % - - -111.52 -10.02 -19.07

Competitive Comparison of Sipai Health Technology Co's ROE %

For the Medical Distribution subindustry, Sipai Health Technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's ROE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's ROE % falls into.



Sipai Health Technology Co ROE % Calculation

Sipai Health Technology Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-279.754/( (2051.294+1770.674)/ 2 )
=-279.754/1910.984
=-14.64 %

Sipai Health Technology Co's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-357.55/( (1979.088+1770.674)/ 2 )
=-357.55/1874.881
=-19.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Sipai Health Technology Co  (HKSE:00314) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-357.55/1874.881
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-357.55 / 4974.836)*(4974.836 / 3151.165)*(3151.165 / 1874.881)
=Net Margin %*Asset Turnover*Equity Multiplier
=-7.19 %*1.5787*1.6807
=ROA %*Equity Multiplier
=-11.35 %*1.6807
=-19.07 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-357.55/1874.881
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-357.55 / -347.752) * (-347.752 / -297.622) * (-297.622 / 4974.836) * (4974.836 / 3151.165) * (3151.165 / 1874.881)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0282 * 1.1684 * -5.98 % * 1.5787 * 1.6807
=-19.07 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sipai Health Technology Co ROE % Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (HKSE:00314) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines